Recent Finacing
Recent Raise
Syntiron is a biotech company developing an antimicrobial‑resistance maternal vaccine targeting Escherichia coli and Klebsiella pneumoniae to prevent neonatal sepsis and maternal urinary tract infections.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Syntiron.
